BBIO

BridgeBio Pharma, Inc.NASDAQHealthcare

$73.15-1.75%ClosedMarket Cap: $14.18B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-18	Mizuho	—	Outperform	—
2026-03-10	JP Morgan	—	Overweight	—
2026-02-25	Truist Securities	—	Buy	—
2026-02-25	Morgan Stanley	—	Overweight	—
2026-02-25	Oppenheimer	—	Outperform	—
2026-02-25	Evercore ISI Group	—	Outperform	—
2026-02-17	HC Wainwright & Co.	—	Buy	—
2026-02-13	Wells Fargo	—	Overweight	—
2026-01-08	Truist Securities	—	Buy	—
2025-12-15	Leerink Partners	—	Outperform	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$0.69	$1.60B	12
Sun Dec 31	$3.70	$2.44B	15
Mon Dec 31	$6.64	$3.33B	10
Tue Dec 31	$8.89	$4.12B	6